Malkin, Samuel J. P. https://orcid.org/0000-0003-1306-7784
Carvalho, Davide
Costa, Catarina
Conde, Vasco
Hunt, Barnaby
Funding for this research was provided by:
Novo Nordisk Portugal, Lda
Article History
Received: 24 November 2021
Accepted: 31 January 2022
First Online: 14 February 2022
Declarations
:
: Not applicable.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: Samuel Malkin and Barnaby Hunt are employees of Ossian Health Economics and Communications GmbH. Ossian received consulting fees from Novo Nordisk Portugal, Lda to support preparation of the analysis. Davide Carvalho is a study investigator for clinical trials sponsored by Novo Nordisk, and has acted as a speaker for Novo Nordisk. Catarina Costa and Vasco Conde are both employees of Novo Nordisk Portugal, Lda.